{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:35:52Z","timestamp":1791995752027,"version":"4.4.0"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1001\/jamapediatrics.2021.5547","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T14:37:39Z","timestamp":1642516659000},"page":"253","source":"Crossref","is-referenced-by-count":148,"title":["Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children"],"prefix":"10.1001","volume":"176","author":[{"given":"Derek J.","family":"Williams","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Monroe Carell Jr Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Buddy","family":"Creech","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University School of Medicine, Monroe Carell Jr Children\u2019s Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Duke Human Vaccine Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Pittsburgh School of Medicine, the UPMC Children\u2019s Hospital of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Gerber","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"},{"name":"Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason G.","family":"Newland","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Howard","sequence":"additional","affiliation":[{"name":"University of Arkansas Medical School, Little Rock"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Hofto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Alabama at Birmingham School of Medicine, Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary A.","family":"Staat","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randolph E.","family":"Oler","sequence":"additional","affiliation":[{"name":"The Emmes Company LLC, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonifride","family":"Tuyishimire","sequence":"additional","affiliation":[{"name":"The Emmes Company LLC, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Conrad","sequence":"additional","affiliation":[{"name":"The Emmes Company LLC, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina S.","family":"Lee","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varduhi","family":"Ghazaryan","sequence":"additional","affiliation":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda M","family":"Pettigrew","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Evans","sequence":"additional","affiliation":[{"name":"Biostatistics Center, Milken Institute School of Public Health, George Washington University, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Charles","family":"Huskins","sequence":"additional","affiliation":[{"name":"Mayo Clinic College of Medicine and Science, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and The DMID 14-0079 Study Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"poi210080r1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1542\/peds.2010-2008","article-title":"Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994-2007.","volume":"127","author":"Kronman","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"poi210080r2","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi210080r3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1086\/526535","article-title":"The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile.","volume":"46","author":"Rice","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi210080r4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMp1215093","article-title":"The future of antibiotics and resistance.","volume":"368","author":"Spellberg","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"poi210080r5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1912400","article-title":"Amoxicillin for 3 or 5 Days for chest-indrawing pneumonia in Malawian children.","volume":"383","author":"Ginsburg","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"poi210080r6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/INF.0000000000000023","article-title":"Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial.","volume":"33","author":"Greenberg","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"poi210080r7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jamapediatrics.2020.6735","article-title":"Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the SAFER Randomized Clinical Trial.","volume":"175","author":"Pernica","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"3","key":"poi210080r8","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrmicro1614","article-title":"The antibiotic resistome: the nexus of chemical and genetic diversity.","volume":"5","author":"Wright","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"poi210080r9","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/cid\/civ495","article-title":"Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR).","volume":"61","author":"Evans","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"10","key":"poi210080r10","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1093\/cid\/ciy766","article-title":"Good studies evaluate the disease while great studies evaluate the patient: development and application of a desirability of outcome ranking endpoint for Staphylococcus aureus bloodstream infection.","volume":"68","author":"Doernberg","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"poi210080r11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1177\/1740774520941441","article-title":"Methodologies for pragmatic and efficient assessment of benefits and harms: application to the SOCRATES trial.","volume":"17","author":"Evans","year":"2020","journal-title":"Clin Trials"},{"issue":"8","key":"poi210080r12","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/cid\/ciz460","article-title":"The emperor\u2019s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with methicillin-resistant Staphylococcus aureus bloodstream infections (PROVIDE).","volume":"70","author":"Lodise","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"poi210080r13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae.","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"poi210080r14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study.","volume":"20","author":"van Duin","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"poi210080r15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ygeno.2011.05.009","article-title":"Btrim: a fast, lightweight adapter and quality trimming program for next-generation sequencing technologies.","volume":"98","author":"Kong","year":"2011","journal-title":"Genomics"},{"issue":"13","key":"poi210080r16","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/bioinformatics\/bty053","article-title":"ARGs-OAP v2.0 with an expanded SARG database and hidden Markov models for enhancement characterization and quantification of antibiotic resistance genes in environmental metagenomes.","volume":"34","author":"Yin","year":"2018","journal-title":"Bioinformatics"},{"issue":"360","key":"poi210080r18","first-page":"835","article-title":"Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.","volume":"9336","author":"Pakistan Multicentre Amoxycillin Short Course Therapy (MASCOT) pneumonia study group","year":"2002","journal-title":"Lancet"},{"issue":"7443","key":"poi210080r19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","article-title":"Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.","volume":"328","author":"Agarwal","year":"2004","journal-title":"BMJ"},{"issue":"2","key":"poi210080r20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.7326\/M19-1491","article-title":"Presenting risks and benefits: helping the data monitoring committee do its job.","volume":"172","author":"Evans","year":"2020","journal-title":"Ann Intern Med"},{"key":"poi210080r17","unstructured":"World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. Accessed March 1, 2021. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/137319\/9789241507813_eng.pdf?sequence=1"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2788071\/jamapediatrics_williams_2022_oi_210080_1646329686.28064.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T11:06:39Z","timestamp":1646651199000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2788071"}},"subtitle":["The SCOUT-CAP Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2021.5547","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}